Bioequivalence Study of Desogestrel Tablets in Healthy Thai Female Volunteers

Phase 1, randomised, open-label trial of desogestrel in contraception (2 arms), sponsored by Bio-innova. Primary endpoints: Area under the plasma concentration-time curve from time zero to the last measurable concentration at 72.00 hours and Maximal measured plasma concentration at 72.00 hours. Planned start Jul 2024; status: not yet recruiting.